Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Abstract: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, with a continuously high mortality. Thus, the development of new therapeutic strategies is crucial to decrease recurrence rates and to improve the overall survival rates of HCC patients. The rationale for immunotherapy is based on the findings of several studies showing specific CD8+ T-cell responses against various tumor-associated antigens (TAAs) in HCC patients and a clinical benefit of T-cell infiltration in the tumor tissue. However, the impact of TAA-specific CD8+ T-cell responses on tumor control seems to be rather weak. Several different mechanisms contribute to the failure of the cellular immune response and will be summarized in this review. The aim of immune-based therapies is to overcome these mechanisms of T-cell failure and to induce or boost TAA-specific CD8+ and CD4+ T-cell responses. Several preclinical and clinical studies of immune-based therapeutic approaches show encouraging results and will be discussed in this review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Digestive diseases. - 30, 5 (2012) , 483-491, ISSN: 1421-9875
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- DOI
-
10.1159/000341697
- URN
-
urn:nbn:de:bsz:25-freidok-1063898
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2019
Ähnliche Objekte (12)
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
Focus management of portal, mesenteric vein thrombosis : invited articles, interdisciplinary discussion
XX. Gastroenterologie-Seminarwoche Titisee : Seminar 2024, Titisee : Beiträge : 24.-28. Februar 2024
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie
Tumorantigen-spezifische CD8+ T-Zellen bei Patienten mit hepatozellulaerem Karzinom
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
CD8-T-Zell-Differenzierung bei Patienten mit Common Variable Immunodeficiency
Successful two-sided sponge pull-through treatment of anastomotic leakage following pancreaticoduodenectomy with pancreaticogastrostomy
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
Focus management of portal, mesenteric vein thrombosis : invited articles, interdisciplinary discussion
XX. Gastroenterologie-Seminarwoche Titisee : Seminar 2024, Titisee : Beiträge : 24.-28. Februar 2024
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie
Tumorantigen-spezifische CD8+ T-Zellen bei Patienten mit hepatozellulaerem Karzinom
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
CD8-T-Zell-Differenzierung bei Patienten mit Common Variable Immunodeficiency
Successful two-sided sponge pull-through treatment of anastomotic leakage following pancreaticoduodenectomy with pancreaticogastrostomy
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox
Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy
Focus management of portal, mesenteric vein thrombosis : invited articles, interdisciplinary discussion
XX. Gastroenterologie-Seminarwoche Titisee : Seminar 2024, Titisee : Beiträge : 24.-28. Februar 2024
Der transjuguläre intrahepatische portosystemische Shunt (TIPS) in der Therapie der portalen Hypertension: Indikation, Stentauswahl, Langzeitverlauf, Komplikationen und prognostische Faktoren in einer retrospektiven monozentrischen Studie
Tumorantigen-spezifische CD8+ T-Zellen bei Patienten mit hepatozellulaerem Karzinom
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
CD8-T-Zell-Differenzierung bei Patienten mit Common Variable Immunodeficiency